Which has grown faster, GILD or VRTX?

Over the past five years, VRTX grew revenue faster — GILD at a 2.72% CAGR versus VRTX at 13.57%.

Does GILD or VRTX pay a bigger dividend?

GILD pays a dividend (2.22% yield), while VRTX has no payments in the available dividend history.

Is GILD or VRTX more profitable?

VRTX runs the higher net margin — GILD at -10.64% versus VRTX at 34.89%.

How have GILD and VRTX total returns compared?

Over the past 10 years, GILD delivered 10.21% and VRTX delivered 18.72% annualized total return. Past performance doesn't predict future results.

Gilead Sciences, Inc. (GILD) vs Vertex Pharmaceuticals Incorporated (VRTX)

A side-by-side comparison of Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

GILD

Gilead Sciences, Inc.

$178.44B

$143.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

VRTX

Vertex Pharmaceuticals Incorporated

$130.82B

$515.44HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — GILD vs VRTX

growth of $100 · dividends reinvested · last 10y

GILD +164.6% (+10.2%/yr)VRTX +462.1% (+18.8%/yr)VRTX compounded faster over this window

GILD VRTX

GILD vs VRTX: by the numbers

•GILD is the larger company ($178.44B vs $130.82B market cap).
•VRTX is profitable (34.89% net margin) while GILD runs a net loss (-10.64%).
•VRTX grew revenue faster over the past five years (13.57% vs 2.72% CAGR).
•GILD pays a dividend (2.22% yield), while VRTX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	GILD	VRTX
P/E ratio	N/A	30.00
Forward P/E	N/A	27.49
P/S ratio	5.86	10.36
P/B ratio	15.09	6.46
EV / EBITDA	N/A	24.88
FCF yield	7.27%	2.90%

Profitability

Metric	GILD	VRTX
Gross margin	79.59%	86.04%
Operating margin	39.74%	38.59%
Net margin	-10.64%	34.89%
ROE	-27.39%	21.76%
ROIC	-3.66%	17.33%

Dividends

Metric	GILD	VRTX
Dividend yield	2.22%	N/A

Growth (annualized)

Metric	GILD	VRTX
Revenue CAGR (5Y)	2.72%	13.57%
EPS CAGR (5Y)	133.83%	8.17%
FCF CAGR (5Y)	9.27%	16.39%
Total return CAGR (5Y)	19.60%	22.61%

Frequently asked

Which has grown faster, GILD or VRTX?: Over the past five years, VRTX grew revenue faster — GILD at a 2.72% CAGR versus VRTX at 13.57%.
Does GILD or VRTX pay a bigger dividend?: GILD pays a dividend (2.22% yield), while VRTX has no payments in the available dividend history.
Is GILD or VRTX more profitable?: VRTX runs the higher net margin — GILD at -10.64% versus VRTX at 34.89%.
How have GILD and VRTX total returns compared?: Over the past 10 years, GILD delivered 10.21% and VRTX delivered 18.72% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GILD analysis Full VRTX analysis Interactive comparison tool

Dig into the metrics

Vertex Pharmaceuticals P/E ratio Gilead Sciences dividend yield Gilead Sciences ROE Vertex Pharmaceuticals ROE Gilead Sciences operating margin Vertex Pharmaceuticals operating margin Gilead Sciences revenue growth Vertex Pharmaceuticals revenue growth Gilead Sciences free cash flow Vertex Pharmaceuticals free cash flow

Gilead Sciences & Vertex Pharmaceuticals appear in these rankings

Highest Dividend Yield Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.